Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Arthritis Research & Therapy|November 1, 2014
Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)William P Kennedy, J Abraham Simon, Carolyn Offutt, et al.The Journal of Rheumatology|September 6, 2005
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanerceptJohn C Davis, Désirée M F M Van der Heijde, Maxime Dougados, et al.Journal of Magnetic Resonance Imaging : JMRI|March 21, 2019
Prospective evaluation of MRI compared with CT for the etiology of abdominal pain in emergency department patients with concern for appendicitisJohn B Harringa, Rebecca L Bracken, John C Davis, et al.Clinical Trials (London, England)|December 25, 2009
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung studyVivien M Hsu, Dinesh Khanna, Edwin Smith, et al.Arthritis and Rheumatism|June 28, 2006
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trialDésirée van der Heijde, Alan Kivitz, Michael H Schiff, et al.The American Journal of Cardiology|March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)Amos Baruch, Sofia Mosesova, John D Davis, et al.Clinical Cardiology|March 23, 2017
A phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9Amos Baruch, Diana Luca, Robert S Kahn, et al.Arthritis and Rheumatism|November 1, 2008
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trialRobert D Inman, John C Davis, Désirée van der Heijde, et al.Arthritis and Rheumatism|April 29, 2008
Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosisPeter K Wung, Troy Anderson, Kevin R Fontaine, et al.Arthritis Care & Research|March 2, 2010
Development and validation of a case ascertainment tool for ankylosing spondylitisMichael H Weisman, Lan Chen, Daniel O Clegg, et al.Pageof 8